• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

bauschhealth

Clinical trials ramping up for potential coronavirus-fighting drugs

April 13, 2020 By Sean Whooley

Bausch Health (NYSE:BHC) announced today that it initiated a clinical trial program in Canada to investigate the use of Virazole for treating COVID-19. With today’s announcement, Bausch joins Eli Lilly (NYSE:LLY) and Care Access Research, which both announced clinical testing of coronavirus therapies last week. Bausch’s Virazole is currently approved in the U.S. and Canada, among other […]

Filed Under: Business/Financial News, Clinical Trials, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: bauschhealth, Care Access Research, coronavirus, COVID-19, Eli Lilly & Co., FDA

Clearside Biomedical inks $76m licensing deal with Bausch for Xipere

October 23, 2019 By Sean Whooley

Clearside Biomedical (NSDQ:CLSD) said yesterday that it entered into a license agreement with Bausch Health Ireland (NYSE:BHC) worth up to $76 million for the Xipere device for the treatment of macular edema associated with uveitis. The agreement grants Bausch an exclusive license to develop, manufacture, distribute, promote, market and commercialize the suprachoroidal injection device. Get the full […]

Filed Under: Business/Financial News, Drug-Device Combinations, Food & Drug Administration (FDA), Optical/Ophthalmic, Pharmaceutical Tagged With: bauschhealth, Clearside Biomedical, FDA

Bausch Health slashes Q1 losses, raises outlook

May 6, 2019 By Brad Perriello

Shares in Bausch Health (NYSE:BHC) got a bump today when the company reported a drastic reduction in first-quarter losses and raised its outlook for the rest of the year. Laval, Quebec-based Bausch reduced its losses by -98.0% to -$52.0 million, or -15¢ per share, on sales growth of 1.1% to $2.02 billion for the three months […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: bauschhealth

Bausch closes $1.5B debt offering, note redemption

March 12, 2019 By Fink Densford

Bausch Health (NYSE:BHC) said late last week that it closed a $1.5 billion offering of senior notes with funds raised slated to support the repurchasing of previously offered senior notes. The Quebec-based company said it closed an offering of $500 million in 5.75% senior secured notes due 2027 and that its Bausch Health Americas business, […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: bauschhealth

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS